Skip to main content

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

December 2015 - FRMC

Department

Conference Insider
12/18/2015
  The development and launch of a new drug is filled with uncertainty. Historically, the pharmaceuti­cal manufacturer has no guarantee of success when investing in research and development, so, upon launch, it tends to seek the highest...
  The development and launch of a new drug is filled with uncertainty. Historically, the pharmaceuti­cal manufacturer has no guarantee of success when investing in research and development, so, upon launch, it tends to seek the highest...
  The development and launch of...
12/18/2015
First Report Managed Care
Conference Insider
12/18/2015
The effects of treatment nonadherence are serious and include poor clinical outcomes, higher mortality, and increased costs and stress on the health care system.
The effects of treatment nonadherence are serious and include poor clinical outcomes, higher mortality, and increased costs and stress on the health care system.
The effects of treatment...
12/18/2015
First Report Managed Care
Conference Insider
12/18/2015
Two care delivery models (accountable care organizations (ACOs) and a specialty pharmacy integrated delivery system) were discussed at an AMCP Nexus session.
Two care delivery models (accountable care organizations (ACOs) and a specialty pharmacy integrated delivery system) were discussed at an AMCP Nexus session.
Two care delivery models...
12/18/2015
First Report Managed Care
Conference Insider
12/18/2015
  A Colorado managed care organization, Rocky Mountain Health Plans (RMHP), aligns clini­cal decision-making through advanced analytics, behavioral health integration, data quality, and improved process, said Patrick Gordon, MPA, as­sociate...
  A Colorado managed care organization, Rocky Mountain Health Plans (RMHP), aligns clini­cal decision-making through advanced analytics, behavioral health integration, data quality, and improved process, said Patrick Gordon, MPA, as­sociate...
  A Colorado managed care...
12/18/2015
First Report Managed Care
Conference Insider
12/18/2015
Total health care costs associated with the use of biologic therapy on patients with psoriasis increased significantly from 2008 to 2013 according to a poster at the 2015 NASP Annual Conference that evaluated cost trends from a US managed...
Total health care costs associated with the use of biologic therapy on patients with psoriasis increased significantly from 2008 to 2013 according to a poster at the 2015 NASP Annual Conference that evaluated cost trends from a US managed...
Total health care costs...
12/18/2015
First Report Managed Care
Conference Insider
12/18/2015
  Implementing a clinical therapy management (CTM) program can have a significant impact on adherence, according to a study involving 178 patients who had at least 1 prescription dispensed for immune globulin (IG) therapy. The study results...
  Implementing a clinical therapy management (CTM) program can have a significant impact on adherence, according to a study involving 178 patients who had at least 1 prescription dispensed for immune globulin (IG) therapy. The study results...
  Implementing a clinical...
12/18/2015
First Report Managed Care
12/18/2015
Are all Co-ops Really Doomed to Fail? Intended to serve as alternatives to the policies offered by for-profit insurers, the nonprofit health insurance co-ops created under the Affordable Care Act have been failing at an alarming rate.  
Are all Co-ops Really Doomed to Fail? Intended to serve as alternatives to the policies offered by for-profit insurers, the nonprofit health insurance co-ops created under the Affordable Care Act have been failing at an alarming rate.  
Are all Co-ops Really Doomed to...
12/18/2015
First Report Managed Care
12/18/2015
Time for the Pharmaceutical Industry to Make its Side Heard Experts defend the worth of the pharmaceutical industry, arguing drug cost is not the greatest challenge to health care spending.  
Time for the Pharmaceutical Industry to Make its Side Heard Experts defend the worth of the pharmaceutical industry, arguing drug cost is not the greatest challenge to health care spending.  
Time for the Pharmaceutical...
12/18/2015
First Report Managed Care
12/18/2015
  By 2018, the sale of specialty drugs is expected to surpass the sales of traditional agents. Inflammatory disease, including rheumatoid ar­thritis (RA), is the most expensive specialty category under the pharmacy benefit, Jeffrey Dunn,...
  By 2018, the sale of specialty drugs is expected to surpass the sales of traditional agents. Inflammatory disease, including rheumatoid ar­thritis (RA), is the most expensive specialty category under the pharmacy benefit, Jeffrey Dunn,...
  By 2018, the sale of...
12/18/2015
First Report Managed Care

Advertisement

Advertisement

Advertisement